1 citations
,
July 2025 in “Diagnostics” In this retrospective study, researchers found a statistically significant increase in the risk of alopecia areata among atopic dermatitis patients using dupilumab compared to controls, suggesting the need for careful monitoring and further research on the drug's impact on alopecia areata.
1 citations
,
November 2024 in “Journal of the American Academy of Dermatology” People with celiac disease have a higher risk of developing alopecia areata.
1 citations
,
February 2024 This study observed that men with anogenital warts had higher prevalence of HPV6/11 in their regional hair samples compared to healthy controls, and patients with HPV6/11-positive hairs were more likely to have visible warts at subsequent visits.
1 citations
,
January 2024 in “The Journal of Dermatology” In this study, Asian breast cancer patients undergoing taxane-based chemotherapy in the adjuvant treatment group reported significantly increased hair loss, higher melanin index, and more wrinkles compared to other treatments, while most neoadjuvant group patients saw hair loss reversed six months post-surgery.
1 citations
,
June 2023 in “Nutrients” This study found that women with polycystic ovary syndrome had deficient or suboptimal serum vitamin D levels, but the effects of vitamin D on metabolic syndrome and hormonal balance remain unclear.
1 citations
,
January 2023 in “Nutrients” This study found that high consumption of sugar-sweetened beverages is associated with an increased risk of male pattern hair loss among young men in mainland China.
1 citations
,
October 2022 in “Cureus” This study found that individuals with chronic skin disorders had significantly higher rates of depression and anxiety compared to a control group, though there was no significant difference in their overall quality of life scores.
1 citations
,
May 2021 in “Scientific Reports” This study identified several anticancer drugs, including vinblastine and bortezomib, that significantly increase the risk of developing chemotherapy-induced peripheral neuropathy, with variations in time-to-onset among different drug categories.
1 citations
,
April 2019 in “Acta medica Philippina” This study found that androgenetic alopecia is significantly associated with an increased risk of Metabolic Syndrome, particularly in early-onset male cases and females exhibiting severe AGA.
1 citations
,
April 2018 in “SLEEP” This study found that veterans with obstructive sleep apnea were nearly twice as likely to develop herpes zoster compared to those without the condition.
1 citations
,
April 2016 in “Journal of The American Academy of Dermatology” People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.
1 citations
,
April 2016 in “Journal of Reproductive Health and Medicine” This article reviews challenges in diagnosing new-onset SLE during pregnancy, emphasizing the complexity of distinguishing it from normal pregnancy changes and preeclampsia, and reports no new results.
1 citations
,
February 2009 in “Clinical Genetics” This study identified new genetic variants on chromosome 20p11 associated with male pattern baldness.
1 citations
,
January 2006 This study found a positive association between bilateral diagonal earlobe crease and bilateral preauricular crease with coronary artery disease, with both creases together predicting the disease with 90% accuracy.
December 2023 in “PubMed” This study reviewed hair loss characteristics in Thai patients post-COVID-19 infection, finding that telogen effluvium commonly occurred 30 days after infection onset, with female gender linked to more severe hair shedding while preexisting androgenetic alopecia was linked to less severe shedding.
January 2023 in “Intisari Sains Medis” This study found a significant relationship between andropause and androgenic alopecia among civil servants at the Badung Regency Government Center.
August 2026 in “Australasian Journal of Dermatology” This study observed that in a real-world pediatric setting, Janus kinase inhibitors led to improvements in scalp, eyebrow, and eyelash involvement in children with alopecia areata, with a generally favorable tolerability profile, though baseline imbalances and non-randomized treatment allocation limit causal conclusions and drug comparisons.
July 2026 in “American Journal of Clinical Dermatology” In this study, oral JAK inhibitors were found to be significantly more effective than placebo in promoting hair regrowth among adults and adolescents with moderate-to-severe alopecia areata, although they were associated with an increased risk of adverse events.
July 2026 in “Endocrine and Metabolic Science” This study found that dyslipidemia was associated with a higher risk of androgenic alopecia in females, driven by low HDL and multiple lipid abnormalities, but not in males.
July 2026 in “American Journal of Sexuality Education” This study found that over 97% of college students at a large Midwestern U.S. university have engaged in pubic hair removal, influenced by demographic and social factors with notable differences in preferences observed across age, gender, Greek Life affiliation, and racial/ethnic groups.
July 2026 in “Journal of the American Academy of Dermatology” GLP-1RA medications may increase the risk of hair loss, especially in non-diabetic people.
June 2026 in “British Journal of Dermatology” This study found that oral JAK inhibitors significantly improve hair regrowth in adults with moderate-to-severe alopecia areata compared to placebo, although they are associated with a higher risk of non-serious adverse events.
May 2026 in “Journal of Clinical Oncology” This study found no evidence of subtype-specific breast cancer risk associated with hair relaxer use among women in Ghana, though the risk was elevated for former users across all subtypes.
April 2026 in “Annals of Medicine” This study observed that serum 25-hydroxyvitamin D deficiency is significantly associated with Alopecia Areata in a North Indian cohort, particularly among urban residents, suggesting that screening for this deficiency could enhance disease management.
This study examined the cardiovascular safety of oral minoxidil, used off-label for androgenetic alopecia, particularly as its usage expands in real-world settings, although specific results were not detailed in the abstract.
January 2026 in “Archives of Dermatological Research” This study found that patients who were hospitalized for COVID-19 were more likely to develop telogen effluvium, a type of hair loss, compared to those treated as outpatients, suggesting a link between COVID-19 severity and this condition.
January 2026 in “Journal of Clinical Medicine” This review identified significant associations between glucose dysregulation and various dermatological conditions like psoriasis and acne, suggesting that dietary interventions and probiotics may help manage related inflammation, highlighting the need for holistic treatment approaches for insulin resistance and metabolic syndrome.
January 2026 in “Journal of Dermatology & Dermatologic Surgery” In this study, rosemary was found to be a common hair care choice among adults in Saudi Arabia, with users reporting mixed perceptions of benefits and side effects; age and prior hair loss treatment use influenced these self-reported outcomes.
December 2025 in “Eurasian Journal of Scientific and Multidisciplinary Research” In this clinical trial involving 60 patients, the Fractional CO2 laser was found to be more effective in achieving significant hair regrowth in alopecia areata compared to intralesional corticosteroid injections, with a 30% absolute improvement and reduced treatment failure rates.
November 2025 in “Journal of Pharmaceutical Research International” This study reviewed 18 studies on the effects of ustekinumab and vedolizumab on alopecia in ulcerative colitis patients, finding varied outcomes ranging from significant hair regrowth to increased hair loss, with 65.5% experiencing regrowth and potential therapy benefits needing further exploration in larger trials.